Published in BMC Health Serv Res on October 25, 2013
Impact of population ageing on the costs of hospitalisations for cardiovascular disease: a population-based data linkage study. BMC Health Serv Res (2014) 0.77
Multiple chronic conditions and healthcare costs among adults. Expert Rev Pharmacoecon Outcomes Res (2015) 0.75
Ageing of population and health care expenditure: a red herring? Health Econ (1999) 4.49
An introduction to Markov modelling for economic evaluation. Pharmacoeconomics (1998) 4.27
Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care (2004) 3.98
The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. Health Aff (Millwood) (2006) 3.75
Longevity and Medicare expenditures. N Engl J Med (1995) 3.51
The effect of longevity on spending for acute and long-term care. N Engl J Med (2000) 2.45
Sex differences in the use of health care services. N Engl J Med (1998) 2.37
The lifetime distribution of health care costs. Health Serv Res (2004) 1.98
Consequences of health trends and medical innovation for the future elderly. Health Aff (Millwood) (2005) 1.95
PopMod: a longitudinal population model with two interacting disease states. Cost Eff Resour Alloc (2003) 1.86
Profile of medical charges for children by health status group and severity level in a Washington State Health Plan. Health Serv Res (2004) 1.68
Predicting future years of healthy life for older adults. J Clin Epidemiol (1998) 1.26
Estimation of the transition matrix of a discrete-time Markov chain. Health Econ (2002) 1.23
The lifetime costs and benefits of medical technology. J Health Econ (2007) 1.21
The developmental origins of health. Health Econ (2012) 1.10
Health expenditure growth: reassessing the threat of ageing. Health Econ (2006) 1.02
Variations in Lifetime Healthcare Costs across a Population. Healthc Policy (2008) 1.00
"The high cost of dying": what do the data show? 1984. Milbank Q (2005) 0.99
Estimates of patient costs related with population morbidity: can indirect costs affect the results? Eur J Health Econ (2010) 0.93
[Measurement of morbidity attended in an integrated health care organization]. Gac Sanit (2009) 0.85
[Effects of population aging on health care expenditure: myths and facts]. Gac Sanit (2001) 0.79
Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology (2005) 1.79
Public transportation and pulmonary tuberculosis, Lima, Peru. Emerg Infect Dis (2007) 1.10
Predictability of drug expenditures: an application using morbidity data. Health Econ (2008) 0.94
A comprehensive analysis of patients' perceptions of continuity of care and their associated factors. Int J Qual Health Care (2013) 0.86
[Measurement of morbidity attended in an integrated health care organization]. Gac Sanit (2009) 0.85
Chromosome territory positioning of conserved homologous chromosomes in different primate species. Chromosoma (2006) 0.85
Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol (2009) 0.80
[An analysis of the diabetic population in a Spanish rural are: morbidity profile, use of resources, complications and metabolic control]. Aten Primaria (2013) 0.79
Hybrid risk adjustment for pharmaceutical benefits. Eur J Health Econ (2008) 0.78
[Public policies and regulation of private health insurance]. Gac Sanit (2005) 0.75